Business Context and Reporting Period
Company: SciSparc Ltd.
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: November 2023 (Report No. 4)
Date of Filing: November 28, 2023
Principal Executive Offices: Tel Aviv, Israel
This filing reports the adoption of a Shareholder Rights Plan (Poison Pill) by the Board of Directors on November 27, 2023, to protect shareholder interests and ensure the Board has sufficient time to evaluate potential control attempts.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and the terms of the newly adopted Rights Plan.
Material Changes and Corporate Actions
- Adoption of Rights Plan: The Board unanimously adopted a Rights Plan to significantly dilute the ownership of any "Acquiring Person" who obtains 10% or more of the Company's Ordinary Shares without Board approval.
- Trigger Threshold: The plan is triggered if a person or group acquires 10% or more of outstanding Ordinary Shares, unless exempted by the Board.
- Grandfathering: Existing holders of 10% or more as of the public announcement are grandfathered, provided they do not increase their ownership by 0.5% or more thereafter.
- Expiration: The Rights Plan has a limited duration and will expire on November 27, 2024.
Terms of the Rights Plan and Management Commentary
Management Commentary: The Board states the plan is intended to fulfill fiduciary duties, enable shareholders to realize long-term value, and encourage potential acquirers to negotiate directly with the Board. It is not intended to prevent transactions in the best interests of the Company.
Key Terms:
- Issuance: One special purchase right ("Right") for each Ordinary Share outstanding on the Record Date (December 8, 2023).
- Exercise Price: $0.001 per Ordinary Share.
- Flip-In Provision: If triggered, holders (excluding the Acquiring Person) may purchase one Ordinary Share for each share they own at the $0.001 price, causing substantial dilution to the Acquiring Person.
- Flip-Over Provision: If the Company is acquired in a merger after the trigger date, Rights holders may purchase shares of the acquiring corporation.
- Redemption: The Board may redeem the Rights at any time prior to the trigger date (Issuance Date).
- Exchange: The Board may exchange Rights for Ordinary Shares at a 1:1 ratio after the trigger date, provided no person owns 50% or more of the Company.
Investor Verification Checklist
- Verify the exact number of Ordinary Shares outstanding as of the Record Date (December 8, 2023) to calculate the total number of Rights issued.
- Review the full Rights Agreement (Exhibit 4.1) for specific definitions of "Acquiring Person," "Affiliates," and exceptions for bona fide swaps dealers.
- Confirm whether any existing shareholders hold 10% or more of the outstanding shares to determine their grandfathered status.
- Monitor for any Board announcements regarding the redemption or termination of the Rights Plan prior to the November 27, 2024 expiration date.
- Check for any subsequent filings regarding amendments to the plan, as the Board retains the right to amend terms prior to the trigger event.